SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cross Country Healthcare Inc. – ‘8-K’ for 2/23/24

On:  Friday, 2/23/24, at 1:53pm ET   ·   For:  2/23/24   ·   Accession #:  1628280-24-6605   ·   File #:  0-33169

Previous ‘8-K’:  ‘8-K’ on 2/21/24 for 2/14/24   ·   Next & Latest:  ‘8-K’ on / for 4/10/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/24  Cross Country Healthcare Inc.     8-K:7,9     2/23/24   11:273K                                   Workiva Inc Wde… FA01/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     29K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      9K 
 6: R1          Cover                                               HTML     45K 
 8: XML         IDEA XML File -- Filing Summary                      XML     12K 
11: XML         XBRL Instance -- ccrn-20240223_htm                   XML     14K 
 7: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- ccrn-20240223_lab                     XML     67K 
 5: EX-101.PRE  XBRL Presentations -- ccrn-20240223_pre              XML     33K 
 3: EX-101.SCH  XBRL Schema -- ccrn-20240223                         XSD     10K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    17K 
10: ZIP         XBRL Zipped Folder -- 0001628280-24-006605-xbrl      Zip     71K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  ccrn-20240223  
 i 0001141103 i FALSE00011411032024-02-232024-02-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549
FORM  i 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)  i February 23, 2024
Filing - Cross Country full logo_2-2024.jpg
 i Cross Country Healthcare, Inc.
(Exact name of registrant as specified in its charter)

 i Delaware
 i 0-33169
 i 13-4066229
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 i 6551 Park of Commerce Boulevard, N.W.,  i Boca Raton,  i FL  i 33487
(Address of Principal Executive Office) (Zip Code)
( i 561)  i 998-2232
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
    Title of each class                 Trading Symbol         Name of each exchange on which registered
 i Common stock, par value $0.0001 per share           i CCRN             i The Nasdaq Stock Market LLC
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 i     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging growth company
 i If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 7.01    Regulation FD Disclosure.

On February 23, 2024, the Company issued a press release, a copy of which is furnished herewith as Exhibit 99.1. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of such section. Furthermore, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

Item 9.01    Financial Statements and Exhibits
(d) Exhibits

          Exhibit     Description
    
  Press Release issued by the Company on February 23, 2024

104.1     Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

  CROSS COUNTRY HEALTHCARE, INC.
    
    
Dated:February 23, 2024By:/s/ William J. Burns
   Name: William J. Burns
   Title: Executive Vice President & Chief Financial Officer
    



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:2/23/2410-K
 List all Filings 
Top
Filing Submission 0001628280-24-006605   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 5:37:10.1pm ET